Anne Mengel

This inventor holds 29 USPTO granted patents and 16 published patent applications and 16 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft, The Broad Institute, Inc.. Active years: 2008-2026.

USPTO Granted Patents = 29 (Patent Applications = 16)

% Patents Active = 41.4

EPO Patents = 16 (Patent Applications = 34)

Average Co-Inventor Count = 12.9

ph-index = 4

Forward Citations = 49(Granted Patents)

Location History:

Berlin, DE (2008 - 2021)
Leverkusen, DE (2022 - 2024)

Company Filing History:

16 out of 386

Bayer Pharma Aktiengesellschaft

patents

10 out of 12,266

Bayer Aktiengesellschaft

patents

9 out of 483

The Broad Institute, Inc.

patents

4. 5 out of 721

Bayer Intellectual Property Gmbh

patents

5. 5 out of 192

Bayer Schering Pharma Ag

patents

6. 2 out of 1,266

Dana-Farber-Cancer Institute Inc.

patents

7. 1 out of 1,409

Schering Aktiengesellschaft

patents

8. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Macrocyclic Indoles

BUB1 Kinase Inhibitors

Anti-Inflammatory Agents

Pharmaceutical Compositions

Indole Derivatives

Pyrimidines

Tetrahydronaphthalene

Sulfoximine

Acylamino

Benzylindazoles

Immuno-Modulators

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12692261 - Substituted heterocyclic compounds and therapeutic uses thereof (2026-07-28),

2. 12565496 - SUBSTITUTED 1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS AND METHODS OF USE THEREOF (2026-03-03),

3. 12338250 - Methods of preparing macrocyclic indoles (2025-06-24),

4. 12227501 - 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors (2025-02-18),

5. 12152041 - Macrocyclic fluorine substituted indole derivatives (2024-11-26),

6. 11891404 - Substituted macrocyclic indole derivatives (2024-02-06),

7. 11478451 - Macrocyclic chlorine substituted indole derivatives (2022-10-25),

8. 11447504 - Macrocyclic chlorine substituted indole derivatives (2022-09-20),

9. 11440923 - Substituted macrocyclic indole derivatives (2022-09-13),

10. 11401278 - Macrocyclic indole derivatives (2022-08-02),

11. 11286263 - Macrocyclic fluorine substituted indole derivatives (2022-03-29),

12. 10894784 - Heteroarylbenzimidazole compounds (2021-01-19),

13. 10604532 - Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases (2020-03-31),

14. 10350206 - Benzyl substituted indazoles as BUB1 inhibitors (2019-07-16),

15. 10266548 - Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases (2019-04-23),

Title: Anne Mengel - Innovative Inventor from Berlin

Introduction: Anne Mengel is a pioneering inventor based in Berlin, Germany, known for her groundbreaking contributions to various technological fields.

Latest Patents: Anne Mengel's most recent patents include advancements in renewable energy technologies, smart home devices, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Anne Mengel has established herself as a leading figure in the innovation landscape, with numerous patents credited to her name. Her work has significantly impacted the way we interact with technology on a daily basis.

Collaborations: Throughout her career, Anne Mengel has collaborated with top research institutions, leading companies, and innovative startups to bring her inventions to life. Her ability to work across different sectors has led to the development of cutting-edge products and solutions.

Conclusion: Anne Mengel's passion for innovation and her dedication to creating a more sustainable future through technology make her a standout figure in the world of inventors. Her work continues to inspire the next generation of innovators to push the boundaries of what is possible.